Harmonic Pharma DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Novo Nordisk's semaglutide delivers in phase 3 MASH study

02 Nov 2024

// FIERCE PHARMA

Argenx sees early launch success for Vyvgart in CIDP

02 Nov 2024

// FIERCE PHARMA

Essa drops lead cancer drug after falling short against Xtandi

02 Nov 2024

// FIERCE BIOTECH

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

PackExpo

Not Confirmed

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

About

Harmonic Pharma has been founded in 2009 with a core technology dedicated to drug repurposing. The company has developed a platform to investigate the mechanism of action of any type of chemicals over the last years. Complementary AI-based solutions have been developed through the dual program entitled Chemical Range to provide public and private organizations with a more comprehensive toxicity profiling. December 2017, Seqens group announced his support to Harmonic Pharma through a capital increase. According to Pierre Luzeau, President of Seqens : “The access to Harmonic Pharma’s technology broadens Seqens’ services.